A panel of pharma planners recently discussed their firms’ in-person possibilities, virtual/hybrid strategies, and compliance considerations for the near future.
Planning veteran Jeffrey Cesari discusses Bristol Myers Squibb’s approach to congresses this year, the linked future of HCP events and internal sales meetings, and the conversations he wants to have at March’s Pharma Forum.
The HMCC designation now has a digital badge for social media and e-signatures.